Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
D000238:Adenoma, Chromophobe / Q000188:drug therapy; D000284:Administration, Oral; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D000818:Animals; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine*; D006065:Gonadotropins, Pituitary / Q000652:urine; D006801:Humans; D007775:Lactation Disorders / Q000188:drug therapy*; D008598:Menstruation; D051379:Mice; D008875:Middle Aged; D010759:Phosphorus Isotopes; D010902:Pituitary Gland / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors* / Q000097:blood / Q000378:metabolism; D011817:Rabbits; D011863:Radioimmunoassay
D006065:Gonadotropins, Pituitary; D010759:Phosphorus Isotopes; D004295:Dihydroxyphenylalanine; D011388:Prolactin; D005640:Follicle Stimulating Hormone